SULIMAN SHEHNAAZ sold 17.0% of their position (5.74K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $144.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/18/2026ACC: 0001713070-26-000002
Director
Since Jan 2019
+16.07K
Net shares
Net buyer
$144.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
21.81K acquired · 5.74K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.75K
Price / share
—
Trade value
—
% of position
29.9%
5/14/2026
25.94K→33.69K
Common Stock
Direct
Shares
−5.74K
Price / share
$25.12
Trade value
$144.19K
% of position
17.0%
5/18/2026
33.69K→27.95K
Total
Net shares
+2.01K
Net value
-$144.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/14/2026 | A · Award | +7.75K | — | — | 29.9% | 25.94K | 33.69K |
| Common Stock Direct | 5/18/2026 | S · Sale | −5.74K | $25.12 | $144.19K | 17.0% | 33.69K | 27.95K |
| Total | +2.01K | -$144.19K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
14.06K shares
Shares
+14.06K
Strike price
25.80
Held after
14.06K
Exercisable
—
5/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock14.06K shares | 5/14/2026 | A · Award | +14.06K | 25.80 | — | 14.06K |